DFTX: Needham Raises PT
Needham maintains buy rating on Definium Therapeutics and raises price target to $50
Needham Maintains Buy on Definium Therapeutics, Raises Price Target to $50
Needham maintains buy rating on Definium Therapeutics and raises price target to $50
Needham Maintains Buy on Definium Therapeutics, Raises Price Target to $50